PROGRAMME Postgraduate Course
Where basic scientists meet clinicians:
Novel insights in microbiota interactions and their clinical utility
Course directors: Annemieke Smet, Benedicte De Winter, Sarah Lebeer,
Nele Brusselaers, Marie Joossens, Lukas Van Oudenhove
Thursday, September 7, 2023
08.30 – 09.40 hrs Session 1: Opening session: State-of-the-art lectures
08.30 – 08.40 hrs
1.1. Course Introduction and Welcome
Annemieke Smet, Antwerp, Belgium
08.40 – 09.10 hrs
1.2. Current understanding of the human microbiome
Martin Blaser, Piscataway, NJ, USA
09.10 – 09.40 hrs
1.3. The microbiome in early life
Maria Gloria Dominguez Bello, Piscataway, NJ, USA
09.40 – 10.10 hrs Coffee Break
10.10 - 12.10 hrs Session 2: Partners in slime - How mucins interact with the microbiota
10.10 – 10.35 hrs
2.1 The past, present and future of mucin-microbe interactions
Malin Johansson, Gothenburg, Sweden
10.35 – 11.00 hrs
2.2. Profiling mucin-degrading microbes in the human gut microbiota
Mindy Engevik, Charleston, SC, USA
11.00 – 11.25 hrs
2.3. Akkermansia muciniphila: a friendly bacterium who cares mucus
Clara Belzer, Wageningen, The Netherlands
11.25 – 11.50 hrs
2.4. Crosstalk between Helicobacter and mucins: a hate and love relationship
Yaron Niv, Tel Aviv, Israel
11.50– 13.00 hrs Lunch Break
13.00 – 14.50 hrsSession 3: Microbiota-organ axes: a microbial outreach and networking
13.00 – 13.25 hrs
3.1. Gut-vaginal microbial crosstalk: implications for women’s health
Henriette Svarre Nielsen, Copenhagen, Denmark
13.25 – 13.50 hrs
3.2. Gut microbiota as driving force in NAFLD development
Max Nieuwdorp, Amsterdam, The Netherlands
13.50 – 14.15 hrs
3.3. Microbiota-Gut-Brain axis: mechanistic insights from rodent studies
Gerard Clarke, Cork, Ireland
14.15 – 14.32 hrs
3.4. From Mice to Men: Translational and Clinical Studies on the Microbiota-Gut-Brain axis | Tandem Talk
Lukas Van Oudenhove, Leuven, Belgium
14.32 – 14.50 hrs
3.5. From Mice to Men: Translational and Clinical Studies on the Microbiota-Gut-Brain axis | Tandem Talk
Boushra Dalile, Leuven, Belgium
14.50 – 16.05 hrs Session 4: Microbial therapy – opportunities and challenges
14.50 – 15.15 hrs
4.1. Culturomics: paradigm shift in the human gut microbiome story
Lars Engstrand, Stockholm, Sweden
15.15 – 15.40 hrs
4.2. In vitro microbiota culture as treatment for dysbiosis
Juan Du, Solna, Sweden
15.40 – 16.05 hrs
4.3. The challenges of microbiota-based interventions
Tomas de Wouters, Schlieren, Switzerland
16.05 – 16.35 hrs Coffee Break
16.35 – 17.50 hrs Session 5: Translating the gut microbiota - ready for the clinic?
16.35 – 17.00 hrs
5.1. Bridging the gap between preclinal and clinical microbial research
Pieter Van den Abbeele, Ghent, Belgium
17.00 – 17.25 hrs
5.2. Translational metabolomics: where are we now?
Herbert Tilg, Innsbruck, Austria
17.25 – 17.50 hrs
5.3. How gut reactions are shaping the immunotherapy outcome in cancer
Nicola Segata, Trento, Italy
17.50 – 18.05 hrs Session 6: Closing
6.1. Annemieke Smet, Antwerp, Belgium
19.00 – 20.00
Welcome Reception | Details to follow